Pediatric Rheumatology Online Journal (Sep 2022)
Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
Abstract
No abstracts available.